Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
humans
100%
women
94%
cancer
54%
kazakhstan
49%
fertility
49%
reviews
42%
risks
38%
screening
37%
ovaries
30%
management
29%
quality of life
29%
environment
27%
workers
27%
menopause
25%
patients
22%
hospitals
17%
oocytes
16%
preservation
15%
diseases
15%
lactobacillus
15%
correlations
14%
genotype
14%
stratification
13%
cysts
13%
pollutants
13%
physiology
13%
epidemiology
13%
burnout
13%
classification
13%
malformations
13%
biopsy
13%
growth factors
13%
candida
13%
communities
13%
toxicity
13%
symptoms
13%
populations
12%
comparative evaluations
11%
surgery
10%
sperm
9%
reserves
8%
levels
7%
men
6%
radiations
6%
detection
6%
chemotherapy
6%
embryos
6%
uterus
6%
in vitro
5%
therapy
5%
Medicine and Dentistry
fertility
32%
Health Care Personnel
30%
Cross Sectional Study
29%
Wart Virus
27%
Cervical Cancer
21%
Papillomavirus Infection
21%
Diseases
18%
Prevalence
17%
Colposcopy
17%
Fertility Preservation
17%
Quality of Life
17%
Cervical Cancer Screening
16%
Triage
15%
Oocyte
13%
Ovarian Reserve
13%
Endometriosis
13%
Cancer Immunization
13%
Cancer Epidemiology
13%
Psychological Aspect
13%
Ovarian Cancer
13%
Genital Malformation
13%
Factor A
13%
Cyst
13%
Cancer Screening
13%
Congenital Malformation
13%
Uterine Fibroid
13%
Burnout
13%
Biopsy Technique
13%
Growth Factor
13%
Pathophysiology
13%
Cancer Growth Factor
13%
Risk Stratification
13%
Tertiary Care
13%
Vasculotropin
13%
Reproductive Age
11%
Carcinogenesis
10%
Ovarian Cyst
10%
Mental Stress
10%
Cancer Therapy
10%
Treatment Option
9%
Infection
8%
Cancer
8%
Human Papillomavirus Type 16
7%
Cancer Incidence
7%
In Vitro Fertilisation
6%
Survival Rate
6%
Assisted Reproductive Technology
6%
Fertility Outcome
6%
Cervix Uteri
6%
Myometrium
6%
Keyphrases
Human Papillomavirus
35%
Kazakhstan
31%
Menopausal Quality of Life
22%
Papillomavirus Infections
18%
Astana
16%
Quality of Life
13%
Healthcare Workers
13%
Diagnostic Risk
13%
Diagnostic Triage
13%
Growth Factor Pathway
13%
Cervical Cancer Screening
13%
Unvaccinated
13%
Uterine Leiomyoma
13%
Vascular Endothelial Growth Factor
13%
Diagnostic Methodology
13%
New Diagnostics
13%
Growth Factors
13%
Risk Stratification
13%
Menopausal Transition
13%
Infection Risk
13%
Transforming Growth Factor-β
13%
Human Papillomavirus Types
13%
Prospective Cohort Study
13%
Vaginal Microbiota
13%
Lactobacillus Iners
13%
Community State Type
13%
High-risk Human Papillomavirus (HR-HPV)
12%
Uterine Fibroids
10%
Co-infection
10%
Human Papillomavirus Genotypes
9%
Cervical Cancer
9%
Novel Diagnostics
7%
Cervical Cancer Prevention
7%
Postmenopause
6%
Fibroids
6%
Genotype Distribution
6%
Mycoplasma Hominis
5%
Infection Outcomes
5%
Quantitative PCR
5%
Human Papillomavirus Genotyping
5%